TY  - GEN
AU  - Hu,Weiwei
AU  - Zheng,Shufang
AU  - Guo,Haixin
AU  - Dai,Beiying
AU  - Ni,Jiaping
AU  - Shi,Yaohong
AU  - Bian,Hanrui
AU  - Li,Lanxin
AU  - Shen,Yumeng
AU  - Wu,Mo
AU  - Tian,Zhoutong
AU  - Liu,Guilai
AU  - Hossain,Md Amir
AU  - Yang,Hongbao
AU  - Wang,Duowei
AU  - Zhang,Qin
AU  - Yu,Jun
AU  - Birnbaumer,Lutz
AU  - Feng,Jifeng
AU  - Yu,Decai
AU  - Yang,Yong
TI  - PLAGL2-EGFR-HIF-1/2α Signaling Loop Promotes HCC Progression and Erlotinib Insensitivity
SN  - 1527-3350
PY  - 2021///0809
KW  - Adult
KW  - Aged
KW  - Animals
KW  - Basic Helix-Loop-Helix Transcription Factors
KW  - metabolism
KW  - Carcinoma, Hepatocellular
KW  - drug therapy
KW  - Cell Line, Tumor
KW  - Cell Movement
KW  - genetics
KW  - Cell Proliferation
KW  - DNA-Binding Proteins
KW  - Disease Progression
KW  - Drug Resistance, Neoplasm
KW  - ErbB Receptors
KW  - antagonists & inhibitors
KW  - Erlotinib Hydrochloride
KW  - pharmacology
KW  - Feedback, Physiological
KW  - Female
KW  - Gene Expression Regulation, Neoplastic
KW  - Gene Knockdown Techniques
KW  - Humans
KW  - Hypoxia-Inducible Factor 1, alpha Subunit
KW  - Kaplan-Meier Estimate
KW  - Liver
KW  - pathology
KW  - Liver Neoplasms
KW  - Male
KW  - Mice
KW  - Middle Aged
KW  - Neoplasm Invasiveness
KW  - RNA-Binding Proteins
KW  - RNA-Seq
KW  - Signal Transduction
KW  - Transcription Factors
KW  - Tumor Hypoxia
KW  - Up-Regulation
KW  - Xenograft Model Antitumor Assays
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1002/hep.31293
ER  -